Heterocyclic Anticancer Agents (Original Publisher)
$40.00
Accelerate your research and deepen your understanding of targeted cancer therapies with Heterocyclic Anticancer Agents. This authoritative eBook explores the cutting-edge role of heterocyclic compounds in anticancer drug design, offering a valuable resource for medicinal chemists, oncological researchers, and pharmaceutical professionals seeking the next breakthrough in cancer treatment.
Description
Heterocyclic Anticancer Agents (1st Edition, 2022), published by Walter de Gruyter, delivers a comprehensive and research-driven analysis of the use of heterocyclic structures in the development of anticancer drugs. Aimed at a specialized audience of medicinal chemists, pharmacologists, oncology researchers, and graduate-level students, this eBook combines chemical synthesis, structure-activity relationships (SAR), and pharmacological evaluations into a single, coherent reference.
As cancer continues to be one of the leading causes of death globally, the demand for innovative and targeted therapies grows. Heterocycles—versatile organic compounds forming the backbone of many pharmaceuticals—are central to the next generation of cancer treatment. This book provides a deep dive into their synthesis, optimization, and biological potential.
Key Features and Highlights
- In-depth exploration of heterocyclic chemistry with a focus on anticancer applications.
- Detailed discussion on drug design strategies, structure-activity relationships, and biological screening.
- Interdisciplinary approach, bridging organic synthesis, medicinal chemistry, and oncology.
- Comprehensive literature reviews of current and emerging heterocyclic compounds with anticancer potential.
- Authored and peer-reviewed by experts in pharmaceutical chemistry and cancer research.
- Ideal for academic researchers, R&D scientists, and graduate students in medicinal chemistry or pharmacology.
Major Topics Covered
- Includes core chapters on synthetic strategies for heterocyclic compounds, SAR analysis, mechanism of action in tumor environments, and the role of nitrogen-, oxygen-, and sulfur-containing heterocycles in cancer therapy.
- Extensive data on molecular targets and resistance mechanisms in various cancer types.
- Covers regulatory and preclinical aspects relevant to drug development pipelines.
About the Author
The contributing authors are leading scholars and researchers in the fields of organic and medicinal chemistry, with extensive publications in peer-reviewed journals. They bring decades of academic and industry experience to this detailed and highly technical work.
Format & Technical Details
- Available Formats: PDF
- File Size: Approx. 5.4 MB
- Language: English
- Device Compatibility: Optimized for all major digital platforms including Kindle, iOS, Android, Windows, and macOS. Fully functional with Adobe Digital Editions and Apple Books.
Frequently Asked Questions
Q1: Is this book suitable for beginners in medicinal chemistry?
A: This book is best suited for advanced students, researchers, and professionals with a foundational understanding of organic chemistry and drug design principles. Beginners may benefit from additional foundational resources.
Q2: Does the book include practical laboratory synthesis methods?
A: Yes, the book includes detailed synthetic routes and methodologies for heterocyclic compounds, along with discussions on pharmacological evaluation and bioassays relevant to cancer therapy.
Additional information
Publisher |
Walter de Gruyter |
---|---|
Published Year |
2022 |
Language |
English |
ISBN |
978-3110739268, 9783110735819, 9783110735772 |
File Size |
107.7 MB |
Edition |
1 |
Reviews
There are no reviews yet.